To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure supply of generic drugs and repeat prescriptions of (a) paracetamol, (b) thyroxine, (c) warfarin and (d) insulin during the covid-19 outbreak.

To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure supply of generic drugs and repeat prescriptions of (a) paracetamol, (b) thyroxine, (c) warfarin and (d) insulin during the covid-19 outbreak.

I am grateful to have secured this Adjournment debate on a very specific issue that was originally raised with me by my constituent Liz Barron, who felt sufficiently strongly and sufficiently affected that she brought supporters from Walsall and Northampton to my Twickenham constituency. I then discovered that the health...

I am grateful to have secured this Adjournment debate on a very specific issue that was originally raised with me by my constituent Liz Barron, who felt sufficiently strongly and sufficiently affected that she brought supporters from Walsall and Northampton to my Twickenham constituency. I then discovered that the health...

I have sought the right hon. Gentleman’s permission to intervene. Does he agree that lab tests are just one part of the diagnostic puzzle and that other steps have been taken to address the fact that between 40% and 50% of patients are either over-treated or under-treated, which massively affects...

I have sought the right hon. Gentleman’s permission to intervene. Does he agree that lab tests are just one part of the diagnostic puzzle and that other steps have been taken to address the fact that between 40% and 50% of patients are either over-treated or under-treated, which massively affects...

There is a lack of precision in this area, and there are questions both on the number of people affected and on the dosages required. I fully take the hon. Gentleman’s point.

We are predominantly dealing with the questions of cost and of physical availability, but let me develop the argument...

There is a lack of precision in this area, and there are questions both on the number of people affected and on the dosages required. I fully take the hon. Gentleman’s point.

We are predominantly dealing with the questions of cost and of physical availability, but let me develop the argument...

I thank the right hon. Member for Twickenham (Sir Vince Cable) for giving us the opportunity to debate this issue. It is unusual for a party leader to lead an Adjournment debate; indeed, this is certainly a first for me. I just note that point. I pay tribute to him...

I thank the right hon. Member for Twickenham (Sir Vince Cable) for giving us the opportunity to debate this issue. It is unusual for a party leader to lead an Adjournment debate; indeed, this is certainly a first for me. I just note that point. I pay tribute to him...

Agreed to on question.

Agreed to on question.

To ask Her Majesty's Government what proportion of patients treated with levothyroxine continue to suffer with symptoms despite adequate biochemical correction.

To ask Her Majesty's Government what proportion of patients treated with levothyroxine continue to suffer with symptoms despite adequate biochemical correction.

To ask Her Majesty's Government what estimate they have made of (1) the additional workload, and (2) the added cost for secondary care providers resulting from the decisions that (a) individuals currently prescribed liothyronine should be reviewed by a consultant NHS endocrinologist with consideration given to switching to levothyroxine where clinically...

To ask Her Majesty's Government what estimate they have made of (1) the additional workload, and (2) the added cost for secondary care providers resulting from the decisions that (a) individuals currently prescribed liothyronine should be reviewed by a consultant NHS endocrinologist with consideration given to switching to levothyroxine where clinically...